202211019

 60 YEARS OLD FEMALE WITH SOB


CASE DETAILS

60 year old female patient came with c/o SOB  since 3 days
SOB ( grade III  progressed to grade IV ) over 3 days
Aggravated while lying down (orthopnea )

HISTORY OF PRESENT ILLNESS 

Pt. was apparently asymptomatic 3 days back then developed SOB  ( grade III  progressed to grade IV ) over 3 days
Aggravated while lying down (orthopnea )
No c/o cough, fever, vomiting, loose stools
No c/o pedal edema 

PAST HISTORY 
 
K/c/o HTN SINCE 10 YEARS and on medication ( metoprolol & Amlodipine tab. )

DM since 5 years and on medication ( metformin & glimiperide tab.)

Not k/c/o CAD, TB, EPILEPSY

PERSONAL HISTORY 
DIET - MIXED
APPETITE - NORMAL
SLEEP - INADEQUATE
BOWEL & BLADDER - REGULAR
NO ADDICTIONS 

GENERAL EXAMINATION 

VITALS 
Pt. Is c/ c/ c
Temp - Afebrile 
B.P. - 160/ 80 mm Hg
P.R - 102 bpm
R.R - 15 cpm
GRBS - 340 mg /dl
Spo2 - 95 % @ 5 lt o2

PHYSICAL EXAMINATION 
PALLOR  -
ICTERUS - 
CYANOSIS -
KOILONYCHIA - 
LYMPHADENOPATHY -
PEDAL EDEMA  -

SYSTEMIC EXAMINATION 
CVS - s1 + , s2 +
RS - BILATERAL CREPTS PRESENT
CNS - NAD
P/A - SOFT , NON TENDER

INVESTIGATIONS :

CBP :
HB - 10.4 
TLC - 14400
PCV - 31.0
PLT - 3.25

RBS - 332
HBA1C - 7.2

RFT :
S.urea - 50
S. Creatinine - 2.2
Na - 139
K - 4.5
Cl - 99

LFT :
T.B - 1.31
D.B - 0.20
AST - 13
ALT - 10
ALP - 184
T.P - 6.7



20/03/2022


UREA - 96
S. CREATININE- 2.5
Na - 137
K - 3.6
Cl - 98


23 /03/2022

UREA - 142
S. CREATININE - 3.2
Na - 133
K - 3.8
Cl - 99

ABG

20/03/2022 

23 /03/2022


USG


2D ECHO


2D ECHO VEDIO


ECG
17/3/2022



19/3/2022


21/03/2022


23/03/2022


CHEST X RAY 

17/3/2022


19 /3/2022

23/03/2022


Provisional diagnosis:

HFrEF 2° TO ?CAD ( EVOLVING MI) - CARDIOGENIC SHOCK  
GLOBAL HYPOKINESIA WITH ALL CHAMBERS DILATED.   SEVERE  MR +/ TR+ 
HTN +, DM + , CKD +(Mod. Lv dysfunction , EF 40 % )

TREATMENT: 

18/03/2022

1.  INJ. LASIX 20 mg IV TID
2. TAB. ECOSPIRIN -AV (75/20) PO / H/S
3. TAB. AMLONG 5MG PO /OD
4. Inj. HUMAN ACTRAPID S/C ACC TO GRBS /TID
5. TAB. PANTOP 40 MG PO /OD
6. TAB. ISOLAZINE 20 MG PO /BD
7. INJ. MONOCEF 1 GM IV/BD
8. TAB. NODOSIS 500 MG PO/TID
9. NEBULISATION ( DUOLIN , BUDECORT ) /TID
10. MONITOR BP , GRBS, INFORM SOS
11.  Fluid RESTICTION ( < 1 LT /DAY)
12. SALT RESTRICTION (< 2GM/ DAY)


19/03/2022

1.  INJ. LASIX 80 mg IV TID ( 80 ---- 40---- 40)
2. TAB. ECOSPIRIN -AV (75/20) PO / H/S
3. TAB. AMLONG 5MG PO /OD
4. Inj. HUMAN ACTRAPID S/C ACC TO GRBS / TID
5. TAB. PANTOP 40 MG PO /OD
6. TAB. ISOLAZINE 20 MG PO /BD
7. INJ. MONOCEF 1 GM IV/BD
8. TAB. NODOSIS 500 MG PO/TID
9. INJ. CLEXANE 60 MG SC /BD
10. NEBULISATION ( DUOLIN , BUDECORT ) /TID
11.  O2 INHALATION - SOS
12. INTERMITTENT NIV SUPPORT 
13. MONITOR BP , GRBS, INFORM SOS

20/03/2022

1.  INJ. LASIX 80 mg IV TID ( 80 ---- 40---- 40)
2. TAB. ECOSPIRIN -AV (75/20) PO / H/S
3. TAB. AMLONG 5MG PO /OD
4. Inj. HUMAN ACTRAPID S/C ACC TO GRBS / TID
5. TAB. PANTOP 40 MG PO /OD
6. TAB. ISOLAZINE 20 MG PO /BD
7. INJ. MONOCEF 1 GM IV/BD
8. TAB. NODOSIS 500 MG PO/TID
9. TAB. MET XL 25 MG PO / OD
10. INJ. CLEXANE 60 MG SC /BD
11. NEBULISATION ( DUOLIN , BUDECORT ) /TID
12.  O2 INHALATION - SOS
13. INTERMITTENT NIV SUPPORT 
14. MONITOR BP , GRBS, INFORM SOS

21/03/2022

1.INJ. NORADRENALINE @10 ML/HR
2. INJ. DOBUTAMINE 1 AMP + 50 ML NS @ 3 ML/HR
3. INJ. LASIX 40 mg IV TID 
4. TAB. ECOSPIRIN -AV (75/20) PO / H/S
5. Inj. HUMAN ACTRAPID S/C ACC TO GRBS / TID
6. TAB. PANTOP 40 MG PO /OD
7. INJ. MONOCEF 1 GM IV/BD
8. TAB. NODOSIS 500 MG PO/TID
9. INJ. CLEXANE 60 MG SC /BD
10. NEBULISATION ( DUOLIN , BUDECORT ) /TID
11.  O2 INHALATION - SOS
12. INTERMITTENT NIV SUPPORT 
13. MONITOR BP , GRBS, INFORM SOS

22/03/2022

1.INJ. NORADRENALINE @20 ML/HR
2. INJ. DOBUTAMINE 250 MG + 50 ML NS @ 4 ML/HR
3. INJ. VASOPRESSIN 1 AMP+ 50 ML NS @ 1 ML / HR
4. INJ. LASIX 40 mg IV TID 
5. TAB. ECOSPIRIN -AV (75/20) PO / H/S
6. Inj. HUMAN ACTRAPID S/C ACC TO GRBS / TID
7. TAB. PANTOP 40 MG PO /OD
8. INJ. MONOCEF 1 GM IV/BD
9. TAB. NODOSIS 500 MG PO/TID
10. INJ. CLEXANE 60 MG SC /BD
11. NEBULISATION ( DUOLIN , BUDECORT ) / BD
12.  O2 INHALATION - SOS
13. INTERMITTENT  CPAP 
14. MONITOR BP , GRBS, INFORM SOS

23/03/2022

1.INJ. NORADRENALINE @20 ML/HR
2. INJ. DOBUTAMINE 250 MG + 50 ML NS @ 4 ML/HR
3. INJ. VASOPRESSIN 1 AMP+ 50 ML NS @ 1 ML / HR
4. INJ. LASIX 40 mg IV TID 
5. TAB. ECOSPIRIN -AV (75/20) PO / H/S
6. Inj. HUMAN ACTRAPID S/C ACC TO GRBS / TID
7. TAB. PANTOP 40 MG PO /OD
8. INJ. MONOCEF 1 GM IV/BD
9. TAB. NODOSIS 500 MG PO/TID
10. INJ. CLEXANE 60 MG SC /BD
11. NEBULISATION ( DUOLIN , BUDECORT ) / BD
12.  O2 INHALATION - SOS
13. INTERMITTENT  CPAP 
14. MONITOR BP , GRBS, INFORM SOS

• Severe resp distress  & pt was intubated on 24/3/22 at 2:45 am

• And had sudden cardiac arrest at 3:15 am

• Cpr 8cycles given

• Death time 3:52 am on 24/3/22

CAUSE OF DEATH :

Comments

Post a Comment

Popular posts from this blog

THESIS

Image
TOPIC: PREDICTORS OF OUTCOMES IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND HEART FAILURE ADMITTED TO A RURAL TERTIARY CARE HOSPITAL PROBLEM STATEMENT: HEART FAILURE is one of the leading cause of death at present all over the world. Inspite of the recent advances and extensive research being done in medical field we are unable to find the exact etiology and predictors of mortality and morbidity in many of the patients with HEART FAILURE and the current mode of treatment is only symptomatic. In a rural setup with limited resources: How far we can eliminate the diagnostic and therapeutic uncertainties that persist in a patient with heart failure and what best we can do to improve their outcomes. INTRODUCTION: Inspite of having advancement in field which helps in diagnosing pulmonary hypertension, it remains the disease that takes lot of time for diagnosis from the presence of first symptom, many patients are diagnosed only in advanced stage of disease. 1 Normal pressure in pulmon
Read more

BIMONTHLY INTERNAL ASSESSMENT - MAY 2021

Image
Section : 1  Please go through the patient data in the links below and answer the following questions: 1) Pulmonology (10 Marks)  A) Link to patient details: https:// soumyanadella128eloggm. blogspot.com/2021/05/a-55- year-old-female-with- shortness-of.html Questions: 1) What is the evolution of the symptomatology in this patient in terms of an event timeline and where is the anatomical localization for the problem and what is the primary etiology of the patient's problem? Symptomatology & event time line: SOB  Grade-II  on & off since 20 Years (exacerbations once in a year) ! Increased frequency & severity of exacerbations since 12 Years ! T2DM since 8 Years ! Anemia 5 yrs back treated with iron sucrose ! Generalized weakness & SOB Grade-II since 30 days ! HTN since 20 days ! Pedal edema & Facial puffiness since 15 days ! SOB Grade-IV & decreased urine output since 2 days Anatomical localization:  Lungs - COPD - SOB Grade- II COPD - PAH - RHF - Pedal edema
Read more

BIMONTHLY INTERNAL ASSESSMENT - DECEMBER

Image
1) A 55 year old man with Recurrent Focal Seizures Detailed patient case report here:  http://ushaindurthi. blogspot.com/2020/11/55-year- old-male-with-complaints-of. html 1. What is the problem representation of this patient and what could be the anatomical site of lesion ? A 55 year old male construction worker with T2DM who is a chronic alcoholic & smoker came with c/o weakness of right upper limb with involuntary movements of both right UL & LL secondary to ? right temporal lobe epileptogenic focus. 2. Why are subcortical internal capsular infarcts more common that cortical infarcts? subcortical infarcts are caused by occlusion of a penetrating artery from a large cerebral artery, most commonly from the Circle of Willis. These penetrating arteries arise at sharp angles from major vessels and are thus, anatomically prone to constriction and occlusion.  So subcortical infarcts are more common than cortical infarcts. https://www.ncbi.nlm.nih.gov/books/NBK534206/#:~:text=Lacuna
Read more